Skip to content
10-Q

Quarterly Report

Baudax Bio, Inc.

0000950170-23-065200

← back to feed
Filed
Nov 20, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 10, 2023 43.59M sh
Shares Diluted Q3 2023 · Sep 30, 2023 7.99M sh
Shares Diluted Q3 2023 · Sep 30, 2023 5.07M sh
Shares Diluted restated Q3 2023 · Sep 30, 2022 295.9K sh
Shares Diluted restated Q3 2023 · Sep 30, 2022 192.14K sh
Capex Q3 2023 · Sep 30, 2023 $21K
Capex restated Q3 2023 · Sep 30, 2022 $0
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$9.68M
Operating Cash Flow restated Q3 2023 · Sep 30, 2022 −$13.1M
Long Term Debt Q3 2023 · Sep 30, 2023 $0
Long Term Debt Q3 2023 · Dec 31, 2022 $1.52M
Short Term Debt Q3 2023 · Sep 30, 2023 $4.23M
Short Term Debt Q3 2023 · Dec 31, 2022 $5.6M
Cash And Equivalents Q3 2023 · Sep 30, 2023 $363K
Cash And Equivalents Q3 2023 · Dec 31, 2022 $5.26M
Stockholders Equity Q3 2023 · Sep 30, 2023 −$10.24M
Stockholders Equity Q3 2023 · Jun 30, 2023 −$10.68M
Stockholders Equity Q3 2023 · Mar 31, 2023 −$7.31M
Stockholders Equity Q3 2023 · Dec 31, 2022 −$24.24M
Stockholders Equity restated Q3 2023 · Sep 30, 2022 −$24.17M
Stockholders Equity restated Q3 2023 · Jun 30, 2022 $4.23M
Stockholders Equity Q3 2023 · Mar 31, 2022 $9.74M
Stockholders Equity Q3 2023 · Dec 31, 2021 $13.23M
Current Liabilities Q3 2023 · Sep 30, 2023 $19.05M
Current Liabilities Q3 2023 · Dec 31, 2022 $21.46M
Total Liabilities Q3 2023 · Sep 30, 2023 $21.78M
Total Liabilities Q3 2023 · Dec 31, 2022 $34.27M
Current Assets Q3 2023 · Sep 30, 2023 $1.34M
Current Assets Q3 2023 · Dec 31, 2022 $6.35M
Total Assets Q3 2023 · Sep 30, 2023 $20.58M
Total Assets Q3 2023 · Dec 31, 2022 $10.03M
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.30
Eps Diluted Q3 2023 · Sep 30, 2023 $0.33
Eps Diluted restated Q3 2023 · Sep 30, 2022 −$98.70
Eps Diluted restated Q3 2023 · Sep 30, 2022 −$257.87
Eps Basic Q3 2023 · Sep 30, 2023 −$0.30
Eps Basic Q3 2023 · Sep 30, 2023 $0.33
Eps Basic restated Q3 2023 · Sep 30, 2022 −$98.70
Eps Basic restated Q3 2023 · Sep 30, 2022 −$257.87
Sga Expense Q3 2023 · Sep 30, 2023 $3.64M
Sga Expense Q3 2023 · Sep 30, 2023 $7.66M
Sga Expense restated Q3 2023 · Sep 30, 2022 $2.95M
Sga Expense restated Q3 2023 · Sep 30, 2022 $12.79M
Rd Expense Q3 2023 · Sep 30, 2023 $1.9M
Rd Expense Q3 2023 · Sep 30, 2023 $6.6M
Rd Expense restated Q3 2023 · Sep 30, 2022 $622K
Rd Expense restated Q3 2023 · Sep 30, 2022 $2.2M
Net Income Q3 2023 · Sep 30, 2023 −$1.93M
Net Income Q3 2023 · Sep 30, 2023 $2.1M
Net Income Q3 2023 · Jun 30, 2023 −$7.38M
Net Income Q3 2023 · Mar 31, 2023 $11.4M
Net Income restated Q3 2023 · Sep 30, 2022 −$29.21M
Net Income restated Q3 2023 · Sep 30, 2022 −$49.55M
Net Income Q3 2023 · Jun 30, 2022 −$7.53M
Net Income Q3 2023 · Mar 31, 2022 −$12.81M
Operating Income Q3 2023 · Sep 30, 2023 −$1.78M
Operating Income Q3 2023 · Sep 30, 2023 −$13.51M
Operating Income restated Q3 2023 · Sep 30, 2022 −$3.58M
Operating Income restated Q3 2023 · Sep 30, 2022 −$14.97M
Revenue Q3 2023 · Sep 30, 2023 $0
Revenue Q3 2023 · Sep 30, 2023 $16K
Revenue Q3 2023 · Sep 30, 2022 $238K
Revenue Q3 2023 · Sep 30, 2022 $959K